Pier 88 Investment Partners’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-2,600
| Closed | -$197K | – | 88 |
|
|
2021
Q4 | $197K | Sell |
2,600
-4,865
| -65% | -$369K | 0.04% | 102 |
|
|
2021
Q3 | $835K | Buy |
7,465
+370
| +5% | +$41.4K | 0.25% | 77 |
|
|
2021
Q2 | $1.15M | Buy |
7,095
+4,300
| +154% | +$696K | 0.33% | 72 |
|
|
2021
Q1 | $341K | Hold |
2,795
| – | – | 0.12% | 102 |
|
|
2020
Q4 | $428K | Sell |
2,795
-5,500
| -66% | -$842K | 0.14% | 101 |
|
|
2020
Q3 | $694K | Sell |
8,295
-12,352
| -60% | -$1.03M | 0.21% | 83 |
|
|
2020
Q2 | $1.52M | Buy |
20,647
+10,317
| +100% | +$758K | 0.43% | 60 |
|
|
2020
Q1 | $438K | Buy |
10,330
+8,790
| +571% | +$373K | 0.16% | 81 |
|
|
2019
Q4 | $94K | Buy |
+1,540
| New | +$94K | 0.04% | 94 |
|